IRVINE, Calif.--(BUSINESS WIRE)--CG Oncology, Inc. today announced the close of an oversubscribed $105 million crossover financing round, co-led by new investors Foresite Capital and TCGX, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results